Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Intra-articular Tranexamic Acid in Knee Replacement
NCT02319915Phase 1Completed
- Sponsor
- CHU Brugmann
- Start
- Feb 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tranexamic acid (2 arms), sponsored by CHU Brugmann. Primary endpoint: Pharmacokinetic profile of tranexamic acid at 24 hours. Started Feb 2015; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT02319915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319915.